Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Immune system wikipedia , lookup
Molecular mimicry wikipedia , lookup
Psychoneuroimmunology wikipedia , lookup
Lymphopoiesis wikipedia , lookup
Polyclonal B cell response wikipedia , lookup
Adaptive immune system wikipedia , lookup
Cancer immunotherapy wikipedia , lookup
International Immunology, Vol. 23, No. 7, pp. 427–431 doi:10.1093/intimm/dxr035 Advance Access publication 10 June 2011 ª The Japanese Society for Immunology. 2011. All rights reserved. For permissions, please e-mail: [email protected] The ‘T-cell-ness’ of NK cells: unexpected similarities between NK cells and T cells Emilie Narni-Mancinelli1,2,3, Eric Vivier1,2,3,4 and Yann M. Kerdiles1,2,3 Centre d’Immunologie de Marseille-Luminy, Université de la Méditerranée, Campus de Luminy case 906, 13288 Marseille, France 2 INSERM U 631, Marseille, France 3 CNRS, UMR 6102, Marseille, France 4 Assistance Publique—Hôpitaux de Marseille, Hôpital de la Conception, 13385 Marseille, France Correspondence to: Y. M. Kerdiles; E-mail: [email protected] Received 16 March 2011, accepted 13 May 2011 Abstract NK cells are considered as prototypical innate immune cells. However, recent discoveries have tended to refine the dogmatic concepts of innate and adaptive immunity. In many ways, NK cells are highly related to T cells and represent the closest innate immune cell lineage to adaptive immune cell populations. Here, we review the relationships between NK cells and T cells and discuss the recently described cell-intrinsic-adaptive features of NK cells. Keywords: adaptive immunity, innate immunity, NK cells, T cells Introduction Historically, the immune system of vertebrates has been divided into two arms: the innate and the adaptive immune systems. Whereas the innate immune system displays a rapid response against infectious agents, the adaptive immune response involves clonal expansion and differentiation of effector cells. Moreover, a fundamental discrepancy between the innate and adaptive immune systems relates to the generation of immune memory in the latter whereby the first encounter with a pathogen is remembered, allowing a more rapid and efficient response upon re-infection with the same pathogen. These adaptive and memory properties were long thought to be restricted to T and B lymphocytes. NK cells are lymphocytes of the innate immune system involved in the control of virus infection and tumor growth by means of cytotoxicity and cytokine secretion. NK cells were originally identified by their ability to lyse tumor cells in the absence of specific prior sensitization. Also, unlike T and B cells, NK cells do not express somatically re-arranged antigen-specific receptors but rely on many germ line-encoded receptors for target recognition. NK cells were thus classified as ‘bona fide’ innate immune cells. Nonetheless, recent findings have revealed that NK cells display cell-intrinsic features normally ascribed to adaptive immune cells. Along this line, bioinformatic analyses of the transcriptional profiles of immune cells have demonstrated that NK cells are even more closely related to T cells than any other immune cell population, including B cells (1, 2), and many cell surface receptors originally identified in NK cells are expressed by subsets of T cells (3); notably, the well-know NKT cell subset, which has been proposed to be a close variant of classical CD4 T cells rather than an intermediate between T and NK cells (4). Illustrating the close and reciprocal relationships between NK and T cells, these data also underpin the existence of shared biological processes between these cell lineages. Here, we review the common traits that exist between NK and T cells and discuss the recently discovered involvement of NK cells in adaptive immune responses. Development NK cells represent the third lymphocyte population in addition to T and B cells. NK cell development is thought to proceed through the sequential differentiation of hematopoietic stem cells into the common lymphoid progenitor and subsequently into NK cell progenitors (NKPs). Years ago, a fetal thymic cell population endowed with T and NK cell differentiation potential was identified (5, 6), suggesting that NK cells could be derived from a bipotent T/NK progenitor lacking B-cell potential. However, unlike B and T cells, NK cell development does not require the expression of the recombination-activating genes (Rag1, Rag2) and proceeds normally in ‘nude’ mice (which are athymic and lack T cells due to mutations in Foxn1) or in human patients with SCID, who lack T and B cells (7). Suggesting that the NK cell lineage would branch out independently of B- and T-cell commitments, NK cell development has REVIEW 1 428 NK and T cell relationships been shown to rely on transcription factors such as E4BP4 and Id2; the deletion of which does not drastically affect B and T cells (8). In addition, a putative NKP phenotype was identified in adult bone marrow (BM) as Lin CD122+ cells (9). When cultured in vitro, these BM cells where shown to be devoid of B- and T-cell potential while efficiently generating lytic NK cells. Nonetheless, in vivo transfer of this cell population into sub-lethally irradiated Il2rg / mice (which lack T, B and NK cells) allows efficient generation of both NK and T cells but not B cells and myeloid cells (10). Although not formally excluding the existence of a different and ‘upstream’ more-restricted NK progenitor, these findings demonstrate the existence of bipotent T/NK progenitors in adult BM. As such, the definitive cell-fate choice toward the classical NKcell lineage or thymus-settling progenitors would occur after the B-cell commitment stage. Further underlying this close developmental relationship between NK and T cells, a thymus-dependent NK cell lineage has recently been described. Like classical NK cells, thymic NK cells express NK1.1 and NKp46 but not CD3, Rag2 or Rorc. However, like T cells or T-cell progenitors, they express CD127 (IL-7Ra), their development and homeostasis rely on Il-7 as well as Gata3 expression and their number is strongly reduced in Foxn1 / nude mice (11). This supports a model in which CD127+ Gata3-dependent thymus-settling progenitors would still not be fully committed to T-cell lineage until Notch-1 engagement and could lead to the generation of this thymic NK cell population. Finally, recent evidence indicates that deletion of the transcription factor Bcl11b in fully committed T-cell precursors is sufficient to induce their reprogramming into cells morphologically, phenotypically, functionally and genetically related to NK cells (12). Altogether, these data highlight that NK cells, despite being described as a prototypical innate immune-cell lineage, are developmentally closer to T cells than the only other RAG-dependent and adaptive immune-cell lineage, i.e. B cells. NK cell ‘repertoire’ and recognition of major histocompatibility complex class I molecules NK cell activation and inhibition is controlled by a balance of signals transduced from NK cell-activating receptors and inhibitory receptors [e.g. Ly49 molecules in mice, killer cell immunoglobulin-like receptors (KIRs) in humans] specific for major histocompatibility complex class I molecules (MHC-I). Interestingly, although NK cells do not express somatically re-arranged antigen-specific receptors like T and B cells, their expression of cell surface receptors still relies on stochastic mechanisms leading to a ‘clonal-like’ expression of combinations of activating and inhibitory receptors (13). Furthermore, NK and T cells represent two immune-cell lineages that are focused on the recognition of MHC molecules. Whereas T-cell activation is triggered through the interaction of the TCR with a peptide–MHC complex displayed by antigen-presenting cells (APCs) or infected cells, the recognition of MHC molecules expressed by target cells through MHC class I-specific inhibitory receptors expressed by NK cells prevents NK-cell activation (14). As such, NK cells act as complementary mechanisms to detect infected or tumoral cells that down-regulate expression of MHC-I molecules and thus preclude their detection by CD8 T cells. It is noteworthy that the NK cell-activating receptors KIR2DS1 in humans and Ly49P in the mouse associate with the immunoreceptor tyrosine-based activation motif-bearing adaptor molecule DAP12/KARAP (DNAXactivating protein of 12 kDa/killer cell-activating receptorassociated protein) and can bind MHC-I molecules as ligands (15, 16). Some NK-activating receptors are thus directly functionally related to the TCR. Education and tolerance The MHC-dependent target-cell recognition strategies displayed by both NK and T cells are also associated with analogous mechanisms regarding their ‘education’ toward MHC recognition. In a murine thymus that lacks expression of MHC molecules, T-cell development is blocked at the double-positive stage. These non-educated T cells are immature and unresponsive to conventional antigen but have to recognize MHC-I or MHC-II molecules in order to be rescued from cell death by neglect and proceed to their final maturation. In a similar way, NK cells from MHC-I-deficient mice or NK cells that do not express receptors specific for MHC-I molecules are hyporesponsive upon stimulation (17, 18). NK and T cells therefore demonstrate a common requirement for MHC recognition in the acquisition of functional competency, although, unlike thymic selection of T cells, this education process of NK cells does not seem to be associated with the deletion of uneducated cell ‘clone-like’ populations. It is noteworthy that wild-type mature NK cells transferred into an MHC-I-deficient host rapidly become hyporesponsive to ex vivo stimulation, suggesting that the MHC-dependent NK cell education is dynamically modulated (19, 20). Furthermore, transgenic expression of the murine cytomegalovirus (MCMV) protein m157, a viral ligand for Ly49H (an NK cell-activating receptor in mice), is also associated with the induction of a functional hyporesponsiveness of endogenous or adoptively transferred Ly49H+ NK cells (21, 22). This dynamic tuning of NK cell responsiveness is reminiscent of the anergic status of T cells under chronic stimulation, which can be reset upon transfer into irradiated host or during overwhelming stimulation (21, 23–25). Taken together, these results suggest that NK and T cells also use common strategies of adaptive peripheral tolerance upon chronic stimulation. Cell ‘priming’ As opposed to their original definition, it is now appreciated that resting NK cells in human and mice are poor effectors at steady state and must be ‘primed’ in order to display their full effector potential. Like T cells, upon infection and inflammation, NK cells are recruited from the blood to the draining lymphoid organs (26–28). Once there, they receive dendritic cell-derived cytokine signals such as IL-15, leading to the transcription of GzmB (granzyme B) and Prf1 (perforin 1) mRNA, the formation of cytotoxic granules, the enhanced ability to secrete IFN-c upon re-stimulation (29–31) and can NK and T cell relationships then re-enter the circulation and migrate to peripheral tissues (30). Therefore, similar to naive T cells and challenging the dogmatic idea that NK cells are ‘immediate effectors’, upon infection, these innate cells would rely on migration to secondary lymphoid organs and dendritic cell-derived signals in order to become fully functional. Of note, IL-18 signaling in vivo is required to maintain optimal responsiveness of NK cells in the steady state (32). In addition, the cytokines IL-12 and IL-18 can synergize to directly activate IFN-c secretion by NK cells, therefore bypassing the need for priming and direct recognition of infected or stressed cells. Illustrating the reciprocal mechanisms acting between NK and memory T cells, such IL-12/IL-18 bystander activation has also been reported for memory CD8 T cells (33–36). Co-stimulatory signals T-cell activation relies on TCR triggering by antigen–MHC complexes and co-stimulatory signals provided by APCs for their activation, optimal proliferation and survival. Similarly, NK cell activation can be modulated by the engagement of co-stimulatory receptors that have been well characterized in T-cell priming. The engagement of CD27, which is a member of the TNF receptor superfamily and is involved in T cell activation, development and T cell-dependent antibody production by B cells, promotes NK cell proliferation and IFN-c production (37). Inducible co-stimulator is induced following TCR activation and is involved in T-cell activation and cytokine production; it also enhances NKG2D-mediated cytotoxicity of activated NK cells against tumor cells (38). Finally, the CD40 ligand (CD40L)–CD40 interaction, which provides an important co-stimulatory signal during T–APC interactions, also indirectly promotes anti-tumor effects of NK cells in vivo (39). Effector functions Unlike many innate immune cells, NK cells are not phagocytic but rather display a panel of effector functions largely overlapping those of T cells. Like CD8 cytotoxic T lymphocytes, NK cells can recognize and induce the lysis of a variety of target cells, including virally infected cells and tumor cells. Upon contact with an appropriate target, both cell types can use perforin/granzyme-dependent as well as Fas ligand-dependent cytotoxic mechanisms. Moreover, like CD4 T cells, a subset of hepatic NK cells can also express TRAIL (TNF-related apoptosis-inducing ligand) (40). Beyond these cytolytic activities, the cytokinesecretion profile displayed by NK cells also paralleled those of activated CD8 T cells and Th1 cells and included the production of large amounts of IFN-c, TNF-a and CC-chemokines, such as CCL3 (MIP-1a), CCL4 (MIP-1b) and CCL5 (RANTES) (41). Importantly, similar to memory T cells but in contrast to naive T cells, proliferation is not required for acquisition of effector functions by NK cells (28, 42, 43). Like memory CD8 T cells, NK cells constitutively express mRNA coding for perforin, granzyme A, granzyme B and IFN-c (29, 31, 44) and their protein expression relies on post-translational mechanisms triggered by inflammatory cytokines such as IL-2, IL-15 or IL-18 (29, 32). The cell-intrinsic mechanisms responsible for the maintenance of this ‘pre-armed’ state of 429 memory CD8 T cells and NK cells are still poorly described, and whether the same mechanisms act in both cell types remains unknown. Nonetheless, it is important to note that like effector and memory CD8 T cells, mature human and mouse NK cells constitutively express the transcription factors T-bet and Eomesodermin. These T-box factors control Ifng, Prf1, GzmB and Il2rb gene expression and are both critically involved in the differentiation and maintenance of CTL, Th1 cells, memory CD8 T cells, as well as NK cells (45–49). In addition, epigenetic modifications such as demethylation and histone acetylation have been observed in the Il2 and Ifng locus of memory CD8 T cells, primary NK cells (50). The parallel expression of transcription factors, post-transcriptional mechanisms and epigenetic modifications could therefore provide common molecular bases for the rapid and vigorous response of NK and memory CD8 T cells upon stimulation. Cell proliferation Like T and B cells, and in contrast to other innate immune cell lineages, it now well demonstrated that NK cells are also endowed with great proliferative potential in situations of viral infections as well as in lymphopenic conditions. Upon MCMV or vesicular stomatitis virus (VSV) infections, a ‘non-specific’ proliferation of NK cells rapidly occurs, presumably driven by cytokines and reminiscent of the bystander proliferation of memory CD8 T cells (50). This initial phase of cell proliferation is followed by a phase of NK cell proliferation and significant expansion that appears to be ‘antigen-specific’ and relies on the triggering of NK cellactivating receptors (50). During MCMV infection, the interaction between the MCMV m157 protein and Ly49H (as mentioned previously) leads to the activation, proliferation and preferential expansion of the Ly49H+ NK cell population (50). Similarly, VSV infection is associated with the preferential expansion of a subset of Ly49H NK cells, suggesting that VSV-derived proteins could also interact with NK cells through specific NK cell-activating receptors (50). Strikingly, whereas Ly49H+ NK cells undergo a roughly 10-fold expansion in the liver during MCMV infection of wildtype mice, this expansion can reach 100- to 1000-fold when the initial frequency of Ly49H+ NK cells is experimentally decreased (51). Therefore, although significant and mimicking the antigen-specific clonal expansion of T cells during an immune response, the NK cell proliferative potential appears to be limited by stringent homeostatic constraints that remain to be identified. Cell-intrinsic role of NK cells in adaptive immune responses Considering the many developmental, functional, phenotypic and genetic similarities between NK cells and T cells, one very intriguing question was whether NK cells could also have the cell-intrinsic ability to mediate adaptive immune responses, i.e. recall or memory responses. A first answer to this question came from seminal studies showing that a subset of liver NK cells was able to mediate the prototypical adaptive immune response of contact hypersensitivity to haptens as well as virus-derived proteins in 430 NK and T cell relationships mice lacking T and B cells (52, 53). NK cells isolated from Rag / mice sensitized with dinitrofluorobenzene, oxazolone, influenza, VSV or HIV-derived proteins and adoptively transferred into naive Rag / Il2rg / mice (lacking T, B and NK cells) confer sensitivity to subsequent challenge with the sensitizing agents as well as increased protection against viral infection, up to 4 months after transfer (52, 53). These results demonstrated that subpopulations of hepatic and pulmonary NK cells possess the intrinsic ability to transfer long-lasting and highly specific immunity to a naive host, a feature only ascribed so far to adaptive immune cells, i.e. T and B cells. Also, as previously mentioned, when transferred into DAP12-deficient mice (defective in Ly49H expression and function), Ly49H+ wild-type NK cells are able to mount a typical adaptive immune response directed against the m157 MCMV protein, including a significant ‘clonal’ expansion followed by a contraction phase (50, 51). Moreover, subsequent viral-challenge experiments have revealed that several weeks later the remaining ‘activationexperienced’ NK cells are able to mount a secondary response with similar kinetics to the primary one but with enhanced effector functions (51). In agreement with these observations, NK cells activated in vitro with a combination of IL-12 and IL-18 and ‘parked’ in vivo also proliferate and display an enhanced ability to secrete IFN-c, regardless of the numbers of cell division, up to 3 weeks later (43). Altogether these studies demonstrate that NK cells have the intrinsic ability to retain an enhanced effector potential along time and upon cell division and support the idea that similar to T cells (and B cells), NK cell activation during an immune response can generate memory NK cells. Concluding remarks Despite the initial description of NK cells as ‘bona fide’ innate immune cells, recent evidence indicates that this classification might not be as clear as expected. Several genetic, phenotypic, developmental and functional studies support the idea that NK cells are related to T cells, culminating with the recent descriptions of cell-intrinsic memory-like features of NK cells. Notably, these last discoveries should also prompt research aiming to re-evaluate the existence of potential adaptive immune features displayed by other innate immune cell types such as macrophages (40). However, before refining the whole concepts of innate and adaptive immunity, it seems important to address some critical issues. Indeed, in sharp contrast with adaptive immune cells, innate immune-cell lineages are characterized by a very rapid turnover of their peripheral pool of effector cells (;15 days for NK cells). Studies on ‘memory-like’ NK cells have been mostly carried out in settings where only the ‘activation-experienced’ cells were able to respond to further stimulation. One can therefore wonder whether these memory-like NK cells are not rapidly diluted by the rapid and constant input of newly produced NK cells in normal physiological settings. Whether the presence of a minute fraction of memory NK cells in a whole NK cell population able to respond to a specific stimulation does make a difference in terms of immune memory efficiency, therefore represents a critical question that has to be addressed. Funding Association pour la Recherche sur Cancer to E.N.M.; Fondation pour la Recherche Médicale to Y.M.K.; The laboratory of E.V. is supported by the Ligue Nationale contre le Cancer (équipe labélisée), INSERM, CNRS, Université de la Méditerranée, Institut Universitaire de France and an ERC advanced Grant References 1 Robbins, S. H., Walzer, T., Dembélé, D. et al. 2008. Novel insights into the relationships between dendritic cell subsets in human and mouse revealed by genome-wide expression profiling. Genome Biol. 9:R17. 2 Yamagata, T., Benoist, C. and Mathis, D. 2006. A shared geneexpression signature in innate-like lymphocytes. Immunol. Rev. 210:52. 3 Vivier, E. and Anfossi, N. 2004. Inhibitory NK-cell receptors on T cells: witness of the past, actors of the future. Nat. Rev. Immunol. 4:190. 4 Wilson, S. B. and Byrne, M. C. 2001. Gene expression in NKT cells: defining a functionally distinct CD1d-restricted T cell subset. Curr. Opin. Immunol. 13:555. 5 Ikawa, T., Kawamoto, H., Fujimoto, S. and Katsura, Y. 1999. Commitment of common T/Natural killer (NK) progenitors to unipotent T and NK progenitors in the murine fetal thymus revealed by a single progenitor assay. J. Exp. Med. 190:1617. 6 Michie, A. M., Carlyle, J. R., Schmitt, T. M. et al. 2000. Clonal characterization of a bipotent T cell and NK cell progenitor in the mouse fetal thymus. J. Immunol. 164:1730. 7 Yokoyama, W. M., Kim, S. and French, A. R. 2004. The dynamic life of natural killer cells. Annu. Rev. Immunol. 22:405. 8 Gascoyne, D. M., Long, E., Veiga-Fernandes, H. et al. 2009. The basic leucine zipper transcription factor E4BP4 is essential for natural killer cell development. Nat. Immunol. 10:1118. 9 Rosmaraki, E. E., Douagi, I., Roth, C., Colucci, F., Cumano, A. and Di Santo, J. P. 2001. Identification of committed NK cell progenitors in adult murine bone marrow. Eur. J. Immunol. 31:1900. 10 Nozad Charoudeh, H., Tang, Y., Cheng, M., Cilio, C. M., Jacobsen, S. E. W. and Sitnicka, E. 2010. Identification of an NK/T cell-restricted progenitor in adult bone marrow contributing to bone marrow- and thymic-dependent NK cells. Blood 116:183. 11 Ribeiro, V. S. G., Hasan, M., Wilson, A. et al. 2010. Cutting edge: thymic NK cells develop independently from T cell precursors. J. Immunol. 185:4993. 12 Li, P., Burke, S., Wang, J. et al. 2010. Reprogramming of T cells to natural killer-like cells upon Bcl11b deletion. Science 329:85. 13 Held, W. and Kunz, B. 1998. An allele-specific, stochastic gene expression process controls the expression of multiple Ly49 family genes and generates a diverse, MHC-specific NK cell receptor repertoire. Eur. J Immunol. 28:2407. 14 Kärre, K. 2008. Natural killer cell recognition of missing self. Nat. Immunol. 9:477. 15 Desrosiers, M. P., Kielczewska, A., Loredo-Osti, J. C. et al. 2005. Epistasis between mouse Klra and major histocompatibility complex class I loci is associated with a new mechanism of natural killer cell–mediated innate resistance to cytomegalovirus infection. Nat. Genet. 37:593. 16 Stewart, C. A., Laugier-Anfossi, F., Vély, F. et al. 2005. Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors. Proc. Natl Acad. Sci. USA. 102:13224. 17 Anfossi, N., André, P., Guia, S. et al. 2006. Human NK cell education by inhibitory receptors for MHC class I. Immunity 25:331. 18 Kim, S., Poursine-Laurent, J., Truscott, S. M. et al. 2005. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436:709. 19 Elliott, J. M., Wahle, J. A. and Yokoyama, W. M. 2010. MHC class I-deficient natural killer cells acquire a licensed phenotype after NK and T cell relationships 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 transfer into an MHC class I-sufficient environment. J. Exp. Med. 207:2073. Joncker, N. T., Shifrin, N., Delebecque, F. and Raulet, D. H. 2010. Mature natural killer cells reset their responsiveness when exposed to an altered MHC environment. J. Exp. Med. 207:2065. Sun, J. C. and Lanier, L. L. 2008. Tolerance of NK cells encountering their viral ligand during development. J. Exp. Med. 205:1819. Tripathy, S. K., Keyel, P. A., Yang, L. et al. 2008. Continuous engagement of a self-specific activation receptor induces NK cell tolerance. J. Exp. Med. 205:1829. Champsaur, M., Beilke, J. N., Ogasawara, K., Koszinowski, U. H., Jonjic, S. and Lanier, L. L. 2010. Intact NKG2D-independent function of NK cells chronically stimulated with the NKG2D ligand Rae-1. J. Immunol. 185:157. Ramsdell, F. and Fowlkes, B. J. 1992. Maintenance of in vivo tolerance by persistence of antigen. Science 257:1130. Yokoyama, W. M. and Kim, S. 2006. Licensing of natural killer cells by self-major histocompatibility complex class I. Immunol. Rev. 214:143. Bajénoff, M., Breart, B., Huang, A. Y. C. et al. 2006. Natural killer cell behavior in lymph nodes revealed by static and real-time imaging. J. Exp. Med. 203:619. Grégoire, C., Cognet, C., Chasson, L. et al. 2008. Intrasplenic trafficking of natural killer cells is redirected by chemokines upon inflammation. Eur. J. Immunol. 38:2076. Martı́n-Fontecha, A., Thomsen, L. L., Brett, S. et al. 2004. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat. Immunol. 5:1260. Fehniger, T. A., Cai, S. F., Cao, X. et al. 2007. Acquisition of murine NK cell cytotoxicity requires the translation of a pre-existing pool of granzyme B and perforin mRNAs. Immunity 26:798. Lucas, M., Schachterle, W., Oberle, K., Aichele, P. and Diefenbach, A. 2007. Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 26:503. Walzer, T., Dalod, M., Robbins, S. H., Zitvogel, L. and Vivier, E. 2005. Natural-killer cells and dendritic cells: ‘l’union fait la force’. Blood 106:2252. Chaix, J., Tessmer, M. S., Hoebe, K. et al. 2008. Cutting edge: priming of NK cells by IL-18. J. Immunol. 181:1627. Berg, R. E., Crossley, E., Murray, S. and Forman, J. 2003. Memory CD8+ T cells provide innate immune protection against Listeria monocytogenes in the absence of cognate antigen. J. Exp. Med. 198:1583. Lertmemongkolchai, G., Cai, G., Hunter, C. A. and Bancroft, G. J. 2001. Bystander activation of CD8+ T cells contributes to the rapid production of IFN-gamma in response to bacterial pathogens. J. Immunol. 166:1097. Raue, H. P., Brien, J. D., Hammarlund, E. and Slifka, M. K. 2004. Activation of virus-specific CD8+ T cells by lipopolysaccharideinduced IL-12 and IL-18. J. Immunol. 173:6873. 431 36 Smeltz, R. B. 2007. Profound enhancement of the IL-12/IL-18 pathway of IFN-gamma secretion in human CD8+ memory T cell subsets via IL-15. J. Immunol. 178:4786. 37 Takeda, K., Oshima, H., Hayakawa, Y. et al. 2000. CD27-mediated activation of murine NK cells. J. Immunol. 164:1741. 38 Ogasawara, K., Yoshinaga, S. K. and Lanier, L. L. 2002. Inducible costimulator costimulates cytotoxic activity and IFN-gamma production in activated murine NK cells. J. Immunol. 169:3676. 39 Nakajima, A., Kodama, T., Morimoto, S. et al. 1998. Antitumor effect of CD40 ligand: elicitation of local and systemic antitumor responses by IL-12 and B7. J. Immunol. 161:1901. 40 Vivier, E., Tomasello, E., Baratin, M., Walzer, T. and Ugolini, S. 2008. Functions of natural killer cells. Nat. Immunol. 9:503. 41 Biron, C. A., Nguyen, K. B., Pien, G. C., Cousens, L. P. and Salazar-Mather, T. P. 1999. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17:189. 42 Bird, J. J., Brown, D. R., Mullen, A. C. et al. 1998. Helper T cell differentiation is controlled by the cell cycle. Immunity 9:229. 43 Cooper, M. A., Elliott, J. M., Keyel, P. A., Yang, L., Carrero, J. A. and Yokoyama, W. M. 2009. Cytokine-induced memory-like natural killer cells. Proc. Natl Acad. Sci. USA 106:1915. 44 Kaech, S. M., Hemby, S., Kersh, E. and Ahmed, R. 2002. Molecular and functional profiling of memory CD8 T cell differentiation. Cell 111:837. 45 Intlekofer, A. M., Banerjee, A., Takemoto, N. et al. 2008. Anomalous type 17 response to viral infection by CD8+ T cells lacking T-bet and eomesodermin. Science 321:408. 46 Intlekofer, A. M., Takemoto, N., Wherry, E. J. et al. 2005. Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin. Nat. Immunol. 6:1236. 47 Pearce, E. L., Mullen, A. C., Martins, G. A. et al. 2003. Control of effector CD8+ T cell function by the transcription factor Eomesodermin. Science 302:1041. 48 Szabo, S. J., Kim, S. T., Costa, G. L., Zhang, X., Fathman, C. G. and Glimcher, L. H. 2000. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100:655. 49 Werneck, M. B. F., Lugo-Villarino, G., Hwang, E. S., Cantor, H. and Glimcher, L. H. 2008. T-bet plays a key role in NK-mediated control of melanoma metastatic disease. J. Immunol. 180:8004. 50 Dokun, A. O., Kim, S., Smith, H. R., Kang, H. S., Chu, D. T. and Yokoyama, W. M. 2001. Specific and nonspecific NK cell activation during virus infection. Nat. Immunol. 2:951. 51 Sun, J. C., Beilke, J. N. and Lanier, L. L. 2009. Adaptive immune features of natural killer cells. Nature 457:557. 52 O’Leary, J. G., Goodarzi, M., Drayton, D. L. and von Andrian, U. H. 2006. T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat. Immunol. 7:507. 53 Paust, S., Gill, H. S., Wang, B. Z. et al. 2010. Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses. Nat. Immunol. 11:1127.